A selective inhibitor of ABCG2
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Product Categories

Research Area

CAY10719

Item No. 20469

Technical Information
Formal Name
[1-(3,4-dichlorophenyl)-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl](4-methoxyphenyl)-methanone
CAS Number
1942919-63-2
Molecular Formula
C25H20Cl2N2O2
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMF: 20 mg/mlDMF:PBS(pH7.2) (1:2): 0.33 mg/mlDMSO: 2 mg/ml
λmax
225 nm
SMILES
COC1=CC=C(C(N2C(C3=CC(Cl)=C(Cl)C=C3)C(NC4=C5C=CC=C4)=C5CC2)=O)C=C1
InChi Code
InChI=1S/C25H20Cl2N2O2/c1-31-17-9-6-15(7-10-17)25(30)29-13-12-19-18-4-2-3-5-22(18)28-23(19)24(29)16-8-11-20(26)21(27)14-16/h2-11,14,24,28H,12-13H2,1H3
InChi Key
AKQFVWUCZTWDKB-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    CAY10719 is a selective inhibitor of the breast cancer resistance protein ABCG2 (IC50 = 0.23 µM) with little activity at ABCG1.1 It has been shown to reverse the ABCG2-mediated resistance toward SN 38 (Item No. 15632) and to inhibit ATPase activity.1

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Spindler, A., Stefan, K., and Wiese, M. Synthesis and investigation of tetrahydro-β-carboline derivatives as inhibitors of the breast cancer resistance protein (ABCG2). J. Med. Chem. 59(13), 6121-6135 (2016).